220 related articles for article (PubMed ID: 15030337)
21. Clinical and prognostic factors in 98 patients with malignant melanoma in China.
Zhang M; Zhang N
J Int Med Res; 2017 Aug; 45(4):1369-1377. PubMed ID: 28587543
[TBL] [Abstract][Full Text] [Related]
22. Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study.
Mezőlaki NE; Baltás E; Ócsai HL; Varga A; Korom I; Varga E; Németh IB; Kis EG; Varga J; Kocsis Á; Gyulai R; Bukva M; Kemény L; Oláh J
Melanoma Res; 2024 Feb; 34(1):54-62. PubMed ID: 37962233
[TBL] [Abstract][Full Text] [Related]
23. Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick.
Gould Rothberg BE; Bulloch KJ; Fine JA; Barnhill RL; Berwick M
Cancer Epidemiol; 2014 Oct; 38(5):599-607. PubMed ID: 25194935
[TBL] [Abstract][Full Text] [Related]
24. Melanoma incidence and mortality in Scotland 1979-2003.
MacKie RM; Bray C; Vestey J; Doherty V; Evans A; Thomson D; Nicolson M;
Br J Cancer; 2007 Jun; 96(11):1772-7. PubMed ID: 17533392
[TBL] [Abstract][Full Text] [Related]
25. Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Ewen T; Husain A; Stefanos N; Barrett P; Jones C; Ness T; Long A; Horswell S; Bosomworth H; Lowenstein J; Richardson G; Swan D; McConnell A; Rose A; Andrew T; Reynolds N; Malvehy J; Carrera C; Alos L; Mailer S; Helm T; Ding L; Bogner P; Podlipnik S; Puig S; McArthur GA; Paragh G; Labus M; Sloan P; Armstrong JL; Lovat PE
Br J Dermatol; 2024 Mar; 190(4):549-558. PubMed ID: 38006317
[TBL] [Abstract][Full Text] [Related]
26. Use of dynamic tissue system adhesive skin closure device and multi-tissue platform porcine xenograft to achieve primary closure after wide local excision of a melanoma.
Zeitouni JF; Collins R; Arledge P; Puckett Y; Ronaghan CF
Wounds; 2024 Mar; 36(3):80-83. PubMed ID: 38684122
[TBL] [Abstract][Full Text] [Related]
27. A national database analysis of the evolution of outcomes of surgery for anal melanoma.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Dourado J; Wexner SD
J Surg Oncol; 2024 Jun; 129(7):1213-1223. PubMed ID: 38533993
[TBL] [Abstract][Full Text] [Related]
28. Association between dermatology follow-up and melanoma survival: A population-based cohort study.
Huang Y; Fleming P; Fung K; Chan AW
J Am Acad Dermatol; 2024 Jun; 90(6):1161-1169. PubMed ID: 38368952
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic challenges in low-grade central osteosarcoma.
Khal AA; Aiba H; Righi A; Gambarotti M; Atherley O'Meally AO; Manfrini M; Donati DM; Errani C
Bone Joint J; 2024 Jan; 106-B(1):99-106. PubMed ID: 38160683
[TBL] [Abstract][Full Text] [Related]
30. Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.
Palacios-Diaz RD; de Unamuno-Bustos B; Pozuelo-Ruiz M; Morales-Tedone EG; Ballester-Sánchez R; Botella-Estrada R
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137712
[TBL] [Abstract][Full Text] [Related]
31. Survival outcomes of head and neck melanoma patients in Queensland, Australia from 2009 to 2018.
Dwivedi N; Barsoum R; Moore J; Rathbone E
Australas J Dermatol; 2023 Nov; 64(4):488-496. PubMed ID: 37606304
[TBL] [Abstract][Full Text] [Related]
32. The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: A retrospective national cohort study.
Xiong DD; Bordeaux J
J Am Acad Dermatol; 2023 Dec; 89(6):1167-1176. PubMed ID: 37625699
[TBL] [Abstract][Full Text] [Related]
33. The role of histological subtypes in the survival of patients diagnosed with cutaneous or mucosal melanoma in the United States of America.
Tabatabai MA; Bahri N; Matthews-Juarez P; Alcendor D; Cooper R; Juarez P; Ramesh A; Tabatabai N; Singh KP; Wilus D
PLoS One; 2023; 18(6):e0286538. PubMed ID: 37276224
[TBL] [Abstract][Full Text] [Related]
34. Poorer survival outcomes in patients with multiple versus single primary melanoma.
Karapetyan L; Yang X; Knight AD; Huang Z; Wang H; Sander CA; Minnier CP; Wilson M; Li A; Karunamurthy A; Storkus WJ; Kirkwood JM
Cancer; 2022 Jun; 128(11):2098-2106. PubMed ID: 35319783
[TBL] [Abstract][Full Text] [Related]
35. Lower limb cutaneous melanoma surgery: location matters.
Piñero-Madrona A; Cerezuela-Fuentes P; Ruiz-Merino G; Martínez-Barba E; Ortiz-Reina S; Martínez-Ortiz MJ; López-Ávila A; Frías-Iniesta JF; Viney A; Cabezas-Herrera J
Arch Dermatol Res; 2023 Sep; 315(7):1971-1978. PubMed ID: 36862181
[TBL] [Abstract][Full Text] [Related]
36. Variation in the practice of wide local excision for melanoma in Ireland and the UK: a questionnaire survey.
O'Connor E; O'Connor C; O'Connell G; Peach H; O'Shea S
Clin Exp Dermatol; 2023 Dec; 49(1):42-45. PubMed ID: 37658870
[TBL] [Abstract][Full Text] [Related]
37. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract][Full Text] [Related]
38. Analysis of prognostic factors for melanoma patients.
Lideikaitė A; Mozūraitienė J; Letautienė S
Acta Med Litu; 2017; 24(1):25-34. PubMed ID: 28630590
[TBL] [Abstract][Full Text] [Related]
39. The UK Government two-week rule and its impact on melanoma prognosis: an evidence-based study.
Pacifico MD; Pearl RA; Grover R
Ann R Coll Surg Engl; 2007 Sep; 89(6):609-15. PubMed ID: 18201477
[TBL] [Abstract][Full Text] [Related]
40. Histopathologic abundance of pigmentation correlates with disease-specific survival in malignant melanoma but is not independent of current AJCC pT stage.
Aebischer V; Abu-Ghazaleh A; Metzler G; Riedl L; Garbe C; Flatz L; Eigentler T; Forchhammer S
Pigment Cell Melanoma Res; 2023 Nov; 36(6):512-521. PubMed ID: 37469279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
